Cardiex Limited (CDX:ASX)

7.5¢

right-arrow Created with Sketch. 0.005 (7.14%)
MCAP $65.03M
Last trade 16.10pm 20/10/2021 20mins delayed

Latest Announcements

15/10/2021CDXCardiex Limited
07/10/2021 Price SensitivePSCDXCardiex Limited
30/09/2021CDXCardiex Limited
158
MCap
30/09/2021CDXCardiex Limited
21/09/2021CDXCardiex Limited
21/09/2021CDXCardiex Limited
20/09/2021CDXCardiex Limited
20/09/2021CDXCardiex Limited

Company Overview

CardieX Limited is an Australia-based global health technology company. The Company is focused on designing, manufacturing and marketing medical devices for use in cardiovascular health management. It operates through its subsidiaries, including ATCOR and CONNEQT. The Company's ATCOR division provides medical devices for measuring arterial stiffness and central blood pressure waveforms based on its FDA-cleared and patented SphygmoCor technology. Under the ATCOR.X brand, the Company also develops and licenses its Arty platform consisting of physiological and health analytics for wearable devices. The company's digital platform, ArtyNet, is a connected software as a service ecosystem providing physicians with a telehealth solution for remotely managing patients' health. CONNEQT develops and markets consumer wearable and home health devices focused on heart health and its patented fitness and wellness parameters.

CDX in the news

CardieX’s (CDX) subsidiary, CONNEQT Inc, enters a manufacturing and development partnership agreement…
CardieX’s (CDX) subsidiary ATCOR and pharmaceutical company Bayer AG enter a new…
CardieX (CDX) subsidiary ATCOR has been granted a new patent for its…
Meditech company CardieX (CDX) has posted another strong quarter of sales despite…

Search Previous Announcements